Table 3. Relationship between levels of Δsv-MALAT1 and FL-MALAT1 and a panel of RTK/MAPK/PI3K proteins in a panel of 143 breast tumours.
Δsv-MALAT1 | FL-MALAT1 | |||
---|---|---|---|---|
ra | P-valuea | ra | P-valuea | |
RTK proteins (n=9) | ||||
EGFR | 0.068 | NS | 0.033 | NS |
p.EGFR.Thr669 | 0.008 | NS | −0.047 | NS |
p.EGFR.Tyr1173 | 0.036 | NS | 0.052 | NS |
Her2/ErbB2 | 0.091 | NS | −0.032 | NS |
Her3/ErbB3 | −0.128 | NS | 0.000 | NS |
p.Her3/Erbb3.Tyr1289 | −0.060 | NS | −0.020 | NS |
p.Her4.Tyr1162 | 0.108 | NS | 0.018 | NS |
Met | −0.025 | NS | −0.029 | NS |
p.Met.Tyr1234.1235 | −0.064 | NS | −0.026 | NS |
MAPK pathway proteins (n=4) | ||||
MEK1/2 | −0.029 | NS | −0.073 | NS |
p.MEK1/2.Ser217/221 | 0.113 | NS | −0.047 | NS |
p44.42.MAPK | 0.116 | NS | 0.150 | NS |
p.p44.42.MAPK.Thr202.Tyr204 | 0.127 | NS | 0.030 | NS |
PI3K/AKT pathway proteins (n=15) | ||||
PTEN | 0.101 | NS | 0.050 | NS |
p.PTEN.Ser380.Thr382.383 | −0.018 | NS | −0.026 | NS |
INPP4b | 0.001 | NS | 0.042 | NS |
Akt1 | 0.030 | NS | −0.017 | NS |
p.Akt1.Ser473 | 0.119 | NS | −0.032 | NS |
Akt2 | −0.102 | NS | 0.028 | NS |
mTor | −0.155 | NS | −0.066 | NS |
p.mTor.Ser2448 | −0.077 | NS | 0.008 | NS |
FOXO1 | −0.194 | 0.0210 | −0.196 | 0.0180 |
TSC2 | −0.075 | NS | 0.003 | NS |
p70.S6.Kinase | −0.172 | 0.0400 | 0.099 | NS |
p.p70.S6.Kinase.Thr389 | −0.225 | 0.0070 | 0.073 | NS |
S6.Ribosomal.protein | −0.034 | NS | 0.075 | NS |
p.S6.Ribosomal.protein.Ser235.236 | −0.095 | NS | 0.006 | NS |
p.S6.Ribosomal.protein.Ser240.244 | −0.201 | 0.0160 | −0.024 | NS |
Abbreviations: Akt=protein kinase B, also known as Akt; EGFR=epidermal growth factor receptor; MAPK=mitogen-activated protein kinase; mTor=mechanistic target of rapamycin; NS=not significant; PI3K=phosphoinositide 3-kinase; PTEN=phosphatase and tensin homologue.
Spearman's rank correlation test.